IRBEK®

IRBEK® is an antihypertensive angiotensin receptor antagonist (ARA II), indicated in the treatment of essential hypertension, also in renal impairment in hypertensive patients with type 2 diabetes.

Additional information

DCI

IRBESARTAN

Dosage

150 mg

Trade name

IRBEK®

Name of the originator

Aprovel

Presentation

30 tablets

Specialty

Cardiologie – Sartans

See also